BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10072506)

  • 1. Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity.
    Kayagaki N; Yamaguchi N; Nakayama M; Kawasaki A; Akiba H; Okumura K; Yagita H
    J Immunol; 1999 Mar; 162(5):2639-47. PubMed ID: 10072506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human small intestinal mucosa harbours a small population of cytolytically active CD8+ alphabeta T lymphocytes.
    Melgar S; Bas A; Hammarström S; Hammarström ML
    Immunology; 2002 Aug; 106(4):476-85. PubMed ID: 12153510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Egr family members regulate nonlymphoid expression of Fas ligand, TRAIL, and tumor necrosis factor during immune responses.
    Droin NM; Pinkoski MJ; Dejardin E; Green DR
    Mol Cell Biol; 2003 Nov; 23(21):7638-47. PubMed ID: 14560009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-related apoptosis-inducing ligand in T cell development: sensitivity of human thymocytes.
    Simon AK; Williams O; Mongkolsapaya J; Jin B; Xu XN; Walczak H; Screaton GR
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5158-63. PubMed ID: 11309507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell-mediated lysis of B cells induced by a CD19xCD3 bispecific single-chain antibody is perforin dependent and death receptor independent.
    Gruen M; Bommert K; Bargou RC
    Cancer Immunol Immunother; 2004 Jul; 53(7):625-32. PubMed ID: 15175907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1 beta converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection.
    Katsikis PD; Garcia-Ojeda ME; Torres-Roca JF; Tijoe IM; Smith CA; Herzenberg LA; Herzenberg LA
    J Exp Med; 1997 Oct; 186(8):1365-72. PubMed ID: 9334376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression.
    Song K; Chen Y; Göke R; Wilmen A; Seidel C; Göke A; Hilliard B; Chen Y
    J Exp Med; 2000 Apr; 191(7):1095-104. PubMed ID: 10748228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo2l.
    Lum JJ; Pilon AA; Sanchez-Dardon J; Phenix BN; Kim JE; Mihowich J; Jamison K; Hawley-Foss N; Lynch DH; Badley AD
    J Virol; 2001 Nov; 75(22):11128-36. PubMed ID: 11602752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated human umbilical cord blood dendritic cells kill tumor cells without damaging normal hematological progenitor cells.
    Shi J; Ikeda K; Fujii N; Kondo E; Shinagawa K; Ishimaru F; Kaneda K; Tanimoto M; Li X; Pu Q
    Cancer Sci; 2005 Feb; 96(2):127-33. PubMed ID: 15723658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both HIV-Infected and Uninfected Cells Express TRAILshort, Which Confers TRAIL Resistance upon Bystander Cells within the Microenvironment.
    Nie Z; Aboulnasr F; Natesampillai S; Burke SP; Krogman A; Bren GD; Chung TDY; Anderson JR; Smart MK; Katzmann DJ; Rajagopalan G; Cummins NW; Badley AD
    J Immunol; 2018 Feb; 200(3):1110-1123. PubMed ID: 29263214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking TRAIL-DR5 signaling pathway with soluble death receptor 5 fusion protein mitigates radiation-induced injury.
    Zhao D; Yang L; Han P; Zhang H; Wang F; Meng Z; Gan H; Wu Z; Sun W; Chen C; Dou G; Gu R
    Front Pharmacol; 2023; 14():1171293. PubMed ID: 37274104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal delivery of TRAIL and miR‑335 for the treatment of hepatocellular carcinoma (Review).
    Thapa N; Chwae YJ; Yoo KH; Won TB; Kang D; Choi D; Kim J
    Int J Mol Med; 2023 Jan; 51(1):. PubMed ID: 36416311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-9 and Interferon-Gamma Are Released by Natural Killer Cells upon Activation with Interferon-Alpha and Orchestrate the Suppression of Hepatitis C Virus Infection.
    Carreca AP; Gaetani M; Busà R; Francipane MG; Gulotta MR; Perricone U; Iannolo G; Russelli G; Carcione C; Conaldi PG; Badami E
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory T Cell-Derived TRAIL Is Not Required for Peripheral Tolerance.
    Dadey RE; Grebinoski S; Zhang Q; Brunazzi EA; Burton A; Workman CJ; Vignali DAA
    Immunohorizons; 2021 Jan; 5(1):48-58. PubMed ID: 33483333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDE5 and PDE10 inhibition activates cGMP/PKG signaling to block Wnt/β-catenin transcription, cancer cell growth, and tumor immunity.
    Piazza GA; Ward A; Chen X; Maxuitenko Y; Coley A; Aboelella NS; Buchsbaum DJ; Boyd MR; Keeton AB; Zhou G
    Drug Discov Today; 2020 Aug; 25(8):1521-1527. PubMed ID: 32562844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of TRAIL/DRs in the Modulation of Immune Cells and Responses.
    Sag D; Ayyildiz ZO; Gunalp S; Wingender G
    Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31574961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of TRAIL Molecular Anatomy in Receptor Oligomerization and Signaling. Implications for Cancer Therapy.
    Naval J; de Miguel D; Gallego-Lleyda A; Anel A; Martinez-Lostao L
    Cancers (Basel); 2019 Mar; 11(4):. PubMed ID: 30934872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Many Th Cell Subsets Have Fas Ligand-Dependent Cytotoxic Potential.
    Kotov DI; Kotov JA; Goldberg MF; Jenkins MK
    J Immunol; 2018 Mar; 200(6):2004-2012. PubMed ID: 29436413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Old game, new players: Linking classical theories to new trends in transplant immunology.
    da Silva MB; da Cunha FF; Terra FF; Camara NO
    World J Transplant; 2017 Feb; 7(1):1-25. PubMed ID: 28280691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onto better TRAILs for cancer treatment.
    de Miguel D; Lemke J; Anel A; Walczak H; Martinez-Lostao L
    Cell Death Differ; 2016 May; 23(5):733-47. PubMed ID: 26943322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.